{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,7,21]],"date-time":"2024-07-21T00:11:47Z","timestamp":1721520707285},"reference-count":18,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,7,20]]},"DOI":"10.7759\/cureus.64998","type":"journal-article","created":{"date-parts":[[2024,7,20]],"date-time":"2024-07-20T17:32:50Z","timestamp":1721496770000},"source":"Crossref","is-referenced-by-count":0,"title":["Categories and Profiles of Uveitis in Vogt-Koyanagi-Harada Syndrome With Systemic Correlation: Inferences From a Tertiary Multispecialty Hospital"],"prefix":"10.7759","author":[{"given":"Simran G","family":"Raichandani","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gowtham","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Radha","family":"Annamalai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sudha","family":"Rangarajan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rajeswari","family":"Sankaralingam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/s0002-9394(01)00925-4","article-title":"Revised diagnostic criteria for Vogt-Koyanagi-Harada disease: report of an international committee on nomenclature","volume":"131","author":"Read RW","year":"2001","unstructured":"Read RW, Holland GN, Rao NA, et al.. Revised diagnostic criteria for Vogt-Koyanagi-Harada disease: report of an international committee on nomenclature. Am J Ophthalmol. 2001, 131:647-52. 10.1016\/s0002-9394(01)00925-4","journal-title":"Am J Ophthalmol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2006.07.040","article-title":"Clinical characteristics of Vogt-Koyanagi-Harada syndrome in Chinese patients","volume":"114","author":"Yang P","year":"2007","unstructured":"Yang P, Ren Y, Li B, Fang W, Meng Q, Kijlstra A. Clinical characteristics of Vogt-Koyanagi-Harada syndrome in Chinese patients. Ophthalmology. 2007, 114:606-14. 10.1016\/j.ophtha.2006.07.040","journal-title":"Ophthalmology"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.587443","article-title":"Integrated analysis of key pathways and drug targets associated with Vogt-Koyanagi-Harada disease","volume":"11","author":"Chen Z","year":"2020","unstructured":"Chen Z, Zhong Z, Zhang W, Su G, Yang P. Integrated analysis of key pathways and drug targets associated with Vogt-Koyanagi-Harada disease. Front Immunol. 2020, 11:587443. 10.3389\/fimmu.2020.587443","journal-title":"Front Immunol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1093\/intimm\/8.5.799","article-title":"Melanocyte lysis by cytotoxic T lymphocytes recognizing the MART-1 melanoma antigen in HLA-A2 patients with Vogt-Koyanagi-Harada disease","volume":"8","author":"Sugita S","year":"1996","unstructured":"Sugita S, Sagawa K, Mochizuki M, Shichijo S, Itoh K. Melanocyte lysis by cytotoxic T lymphocytes recognizing the MART-1 melanoma antigen in HLA-A2 patients with Vogt-Koyanagi-Harada disease. Int Immunol. 1996, 8:799-803. 10.1093\/intimm\/8.5.799","journal-title":"Int Immunol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1136\/bjo.80.11.1002","article-title":"Melanoma specific Th1 cytotoxic T lymphocyte lines in Vogt-Koyanagi-Harada disease","volume":"80","author":"Norose K","year":"1996","unstructured":"Norose K, Yano A. Melanoma specific Th1 cytotoxic T lymphocyte lines in Vogt-Koyanagi-Harada disease. Br J Ophthalmol. 1996, 80:1002-8. 10.1136\/bjo.80.11.1002","journal-title":"Br J Ophthalmol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1001\/archopht.1991.01080050096037","article-title":"Vogt-Koyanagi-Harada syndrome. Clinical course, therapy, and long-term visual outcome","volume":"109","author":"Rubsamen PE","year":"1991","unstructured":"Rubsamen PE, Gass JD. Vogt-Koyanagi-Harada syndrome. Clinical course, therapy, and long-term visual outcome. Arch Ophthalmol. 1991, 109:682-7. 10.1001\/archopht.1991.01080050096037","journal-title":"Arch Ophthalmol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9394(01)00937-0","article-title":"Complications and prognostic factors in Vogt-Koyanagi-Harada disease","volume":"131","author":"Read RW","year":"2001","unstructured":"Read RW, Rechodouni A, Butani N, Johnston R, LaBree LD, Smith RE, Rao NA. Complications and prognostic factors in Vogt-Koyanagi-Harada disease. Am J Ophthalmol. 2001, 131:599-606. 10.1016\/S0002-9394(01)00937-0","journal-title":"Am J Ophthalmol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajo.2005.04.052","article-title":"Vogt-Koyanagi-Harada disease: clinical outcomes","volume":"140","author":"Bykhovskaya I","year":"2005","unstructured":"Bykhovskaya I, Thorne JE, Kempen JH, Dunn JP, Jabs DA. Vogt-Koyanagi-Harada disease: clinical outcomes. Am J Ophthalmol. 2005, 140:674-8. 10.1016\/j.ajo.2005.04.052","journal-title":"Am J Ophthalmol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2016.04.001","article-title":"Vogt-Koyanagi-Harada syndrome: perspectives for immunogenetics, multimodal imaging, and therapeutic options","volume":"15","author":"Silpa-Archa S","year":"2016","unstructured":"Silpa-Archa S, Silpa-Archa N, Preble JM, Foster CS. Vogt-Koyanagi-Harada syndrome: perspectives for immunogenetics, multimodal imaging, and therapeutic options. Autoimmun Rev. 2016, 15:809-19. 10.1016\/j.autrev.2016.04.001","journal-title":"Autoimmun Rev"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1186\/s13023-016-0412-4","article-title":"Vogt-Koyanagi-Harada disease: review of a rare autoimmune disease targeting antigens of melanocytes","volume":"11","author":"Lavezzo MM","year":"2016","unstructured":"Lavezzo MM, Sakata VM, Morita C, et al.. Vogt-Koyanagi-Harada disease: review of a rare autoimmune disease targeting antigens of melanocytes. Orphanet J Rare Dis. 2016, 11:29. 10.1186\/s13023-016-0412-4","journal-title":"Orphanet J Rare Dis"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9394(77)90142-8","article-title":"Vogt-Koyanagi-Harada syndrome","volume":"83","author":"Ohno S","year":"1977","unstructured":"Ohno S, Char DH, Kimura SJ, O'Connor GR. Vogt-Koyanagi-Harada syndrome. Am J Ophthalmol. 1977, 83:735-40. 10.1016\/0002-9394(77)90142-8","journal-title":"Am J Ophthalmol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.3390\/jcm11133632","article-title":"Treatment and prognosis of Vogt-Koyanagi-Harada disease: real-life experience in long-term follow-up","volume":"11","author":"Accorinti M","year":"2022","unstructured":"Accorinti M, Saturno MC, Iannetti L, Manni P, Mastromarino D, Pirraglia MP. Treatment and prognosis of Vogt-Koyanagi-Harada disease: real-life experience in long-term follow-up. J Clin Med. 2022, 11:3632. 10.3390\/jcm11133632","journal-title":"J Clin Med"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2009.08.030","article-title":"Frequency of distinguishing clinical features in Vogt-Koyanagi-Harada disease","volume":"117","author":"Rao NA","year":"2010","unstructured":"Rao NA, Gupta A, Dustin L, et al.. Frequency of distinguishing clinical features in Vogt-Koyanagi-Harada disease. Ophthalmology. 2010, 117:591-9. 10.1016\/j.ophtha.2009.08.030","journal-title":"Ophthalmology"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.2147\/OPTH.S134977","article-title":"Clinical spectrum and management options in Vogt-Koyanagi-Harada disease","volume":"11","author":"Lodhi SA","year":"2017","unstructured":"Lodhi SA, Reddy JL, Peram V. Clinical spectrum and management options in Vogt-Koyanagi-Harada disease. Clin Ophthalmol. 2017, 11:1399-406. 10.2147\/OPTH.S134977","journal-title":"Clin Ophthalmol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1001\/jamaophthalmol.2018.2664","article-title":"Development and evaluation of diagnostic criteria for Vogt-Koyanagi-Harada disease","volume":"136","author":"Yang P","year":"2018","unstructured":"Yang P, Zhong Y, Du L, et al.. Development and evaluation of diagnostic criteria for Vogt-Koyanagi-Harada disease. JAMA Ophthalmol. 2018, 136:1025-31. 10.1001\/jamaophthalmol.2018.2664","journal-title":"JAMA Ophthalmol"},{"key":"ref16","article-title":"Indocyanine green angiography guided management of vogt-koyanagi-harada disease","volume":"6","author":"Bouchenaki N","year":"2011","unstructured":"Bouchenaki N, Herbort CP. Indocyanine green angiography guided management of vogt-koyanagi-harada disease. J Ophthalmic Vis Res. 2011, 6:241-8.","journal-title":"J Ophthalmic Vis Res"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1111\/aos.13189","article-title":"Mycophenolate mofetil combined with systemic corticosteroids prevents progression to chronic recurrent inflammation and development of 'sunset glow fundus' in initial-onset acute uveitis associated with Vogt-Koyanagi-Harada disease","volume":"95","author":"Abu El-Asrar AM","year":"2017","unstructured":"Abu El-Asrar AM, Dosari M, Hemachandran S, Gikandi PW, Al-Muammar A. Mycophenolate mofetil combined with systemic corticosteroids prevents progression to chronic recurrent inflammation and development of 'sunset glow fundus' in initial-onset acute uveitis associated with Vogt-Koyanagi-Harada disease. Acta Ophthalmol. 2017, 95:85-90. 10.1111\/aos.13189","journal-title":"Acta Ophthalmol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.3109\/09273948.2013.856448","article-title":"Vogt-Koyanagi-Harada disease: clinical and demographic characteristics of patients in a specialized eye hospital in Turkey","volume":"22","author":"Ozdal P","year":"2014","unstructured":"Ozdal P, Ozdamar Y, Yazici A, Teke MY, Ozturk F. Vogt-Koyanagi-Harada disease: clinical and demographic characteristics of patients in a specialized eye hospital in Turkey. Ocul Immunol Inflamm. 2014, 22:277-86. 10.3109\/09273948.2013.856448","journal-title":"Ocul Immunol Inflamm"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/260390-categories-and-profiles-of-uveitis-in-vogt-koyanagi-harada-syndrome-with-systemic-correlation-inferences-from-a-tertiary-multispecialty-hospital","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,20]],"date-time":"2024-07-20T17:32:56Z","timestamp":1721496776000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/260390-categories-and-profiles-of-uveitis-in-vogt-koyanagi-harada-syndrome-with-systemic-correlation-inferences-from-a-tertiary-multispecialty-hospital"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,20]]},"references-count":18,"URL":"https:\/\/doi.org\/10.7759\/cureus.64998","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,7,20]]}}}